Plebani Mario, Astion Michael L, Barth Julian H, Chen Wenxiang, de Oliveira Galoro César A, Escuer Mercedes Ibarz, Ivanov Agnes, Miller Warren G, Petinos Penny, Sciacovelli Laura, Shcolnik Wilson, Simundic Ana-Maria, Sumarac Zorica
Clin Chem Lab Med. 2014 Jul;52(7):951-8. doi: 10.1515/cclm-2014-0142.
Quality indicators (QIs) are fundamental tools for enabling users to quantify the quality of all operational processes by comparing it against a defined criterion. QIs data should be collected over time to identify, correct, and continuously monitor defects and improve performance and patient safety by identifying and implementing effective interventions. According to the international standard for medical laboratories accreditation, the laboratory shall establish and periodically review QIs to monitor and evaluate performance throughout critical aspects of pre-, intra-, and post-analytical processes. However, while some interesting programs on indicators in the total testing process have been developed in some countries, there is no consensus for the production of joint recommendations focusing on the adoption of universal QIs and common terminology in the total testing process. A preliminary agreement has been achieved in a Consensus Conference organized in Padua in 2013, after revising the model of quality indicators (MQI) developed by the Working Group on "Laboratory Errors and Patient Safety" of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The consensually accepted list of QIs, which takes into consideration both their importance and applicability, should be tested by all potentially interested clinical laboratories to identify further steps in the harmonization project.
质量指标（QIs）是一种基本工具，可让用户通过将所有运营流程的质量与既定标准进行比较来对其进行量化。应随着时间的推移收集质量指标数据，以识别、纠正并持续监测缺陷，并通过识别和实施有效的干预措施来提高绩效和患者安全。根据医学实验室认可的国际标准，实验室应建立并定期审查质量指标，以监测和评估分析前、分析中和分析后过程关键环节的绩效。然而，尽管一些国家已制定了一些有关总检测过程中指标的有趣方案，但对于制定侧重于在总检测过程中采用通用质量指标和通用术语的联合建议，尚未达成共识。2013年在帕多瓦组织的一次共识会议上，在修订了国际临床化学和检验医学联合会（IFCC）“实验室误差与患者安全”工作组开发的质量指标模型（MQI）之后，达成了初步协议。所有可能感兴趣的临床实验室都应测试这份经协商一致接受的质量指标清单，该清单兼顾了指标的重要性和适用性，以确定协调项目的后续步骤。
